| __timestamp | Lantheus Holdings, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 10811000 |
| Thursday, January 1, 2015 | 78634000 | 33001000 |
| Friday, January 1, 2016 | 75374000 | 64936000 |
| Sunday, January 1, 2017 | 92157000 | 99909000 |
| Monday, January 1, 2018 | 93326000 | 127724000 |
| Tuesday, January 1, 2019 | 103132000 | 161524000 |
| Wednesday, January 1, 2020 | 110171000 | 182933000 |
| Friday, January 1, 2021 | 218817000 | 219982000 |
| Saturday, January 1, 2022 | 233827000 | 278139000 |
| Sunday, January 1, 2023 | 267194000 | 309799000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Lantheus Holdings, Inc. and Ultragenyx Pharmaceutical Inc. have shown distinct trajectories in their SG&A cost management from 2014 to 2023.
Lantheus Holdings, Inc. has demonstrated a steady increase in SG&A expenses, starting from approximately $72 million in 2014 and reaching around $267 million by 2023. This represents a growth of nearly 270%. On the other hand, Ultragenyx Pharmaceutical Inc. began with a modest $11 million in 2014, skyrocketing to about $310 million in 2023, marking an increase of over 2700%.
While both companies have seen significant increases, the rate at which Ultragenyx's expenses have grown is notably higher. This data provides a fascinating insight into how these companies prioritize and manage their operational costs over time.
AbbVie Inc. vs Lantheus Holdings, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Lantheus Holdings, Inc. Trends and Insights
Comparing SG&A Expenses: BeiGene, Ltd. vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Comparing SG&A Expenses: Insmed Incorporated vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Opthea Limited
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs CymaBay Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs ACADIA Pharmaceuticals Inc.
Lantheus Holdings, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Lantheus Holdings, Inc. and Xencor, Inc.: SG&A Spending Patterns Compared